Clinical review: Myocardial depression in sepsis and septic shock.
Myocardial dysfunction frequently accompanies severe sepsis and septic shock. Whereas myocardial depression was previously considered a preterminal event, it is now clear that cardiac dysfunction as evidenced by biventricular dilatation and reduced ejection fraction is present in most patients with severe sepsis and septic shock. Myocardial depression exists despite a fluid resuscitation-dependent hyperdynamic state that typically persists in septic shock patients until death or recovery. Cardiac function usually recovers within 7-10 days in survivors. Myocardial dysfunction does not appear to be due to myocardial hypoperfusion but due to circulating depressant factors, including the cytokines tumor necrosis factor alpha and IL-1beta. At a cellular level, reduced myocardial contractility seems to be induced by both nitric oxide-dependent and nitric oxide-independent mechanisms. The present paper reviews both the clinical manifestations and the molecular/cellular mechanisms of sepsis-induced myocardial depression.
Court
Olivier
O
Section of Critical Care Medicine, Health Sciences Center, University of Manitoba, Winnipeg, Canada.
Kumar
Aseem
A
Parrillo
Joseph E
JE
Kumar
Anand
A
D002303:Cardiac Output, Low / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D009200:Myocardial Contraction; D009569:Nitric Oxide / Q000378:metabolism; D011379:Prognosis; D018805:Sepsis / Q000150:complications* / Q000175:diagnosis; D012772:Shock, Septic / Q000150:complications* / Q000175:diagnosis; D018754:Ventricular Dysfunction / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology*
D016207:Cytokines; D009569:Nitric Oxide